The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
European Commission expands dostarlimab plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer
GSK plc announced today that the European Commission has approved dostarlimab in combination with chemotherapy…